De Faakto

MEDICAL-ALERT-FDA-Multiple Safety

MEDICAL ALERT Food & Drug Administration 1. Maquet Datascope Corp./Getinge Group Recalls the Cardiosave Hybrid and Cardiosave Rescue Intra-Aortic Balloon…

FDA approves new drug to treat influenza-Xofluza (baloxavir marboxil)

Food & Drug Administration approves new drug to treat influenza Xofluza (baloxavir marboxil) Today, the U.S. Food and Drug Administration approved…

De Faakto Intelligence-Women in Combat-an Open Source Study

De Faakto Intelligence Research Observatory   Women in Combat-an Open Source Study Methodology OSINT-research Gaps Disparate Information Situation Combat…

Alert FDA Drug Safety-Recall

From the U.S. Food & Drug Administration   Irbesartan Tablets Sciegen Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Irbesartan Tablets, USP 75…

DE FAAKTO ANALYSIS-Modernizing Navies-OSINT Study

Modernizing Navies-An Open Source Intelligence Study Methodology OSINT-research Situation Countries Modernizing & the Drivers for Navel Modernization Background Modern navel power is essential to any…

K9 Opioid Exposure/Overdose

De Faakto Intelligence Research Observatory K9 Opioid Exposure/Overdose   Methodology OSINT-research Situation K9 Opioid Exposure/Overdose Background Working dogs are…

ALERT-FDA-DRUG SHORTAGE

Food & Drug Administration Drug Shortage Report Trifluoperazine Hydrochloride Tablets Status: Currently in Shortage Date first posted: 10/02/2018 Therapeutic Categories: Psychiatry 1 mg (NDC…

FDA-SAFETY COMMUNICATION-ALERT-Alcon CyPass Micro-Stent

UPDATE: Potential Eye Damage from Alcon CyPass Micro-Stent Used to Treat Open-Angle Glaucoma: FDA Safety Communication 24 October 2018 Audience People who…

FDA SAFETY COMMUNICATION

Food & Drug Administration SAFETY COMMUNICATION Increased Risk of Corneal Haze Associated with the Raindrop Near Vision Inlay: FDA Safety…

FDA ALERT-MEDWATCH

Food & Drug Administration Alert-MEDWATCH 23 October 2018 MedWatch – The FDA Safety Information and Adverse Event Reporting Program A new MedWatch…